Clincosm LogoSign in Get a demo

Keratoconjunctivitis Sicca

Showing NaN - NaN of 5
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Dry Eye Syndromes, Keratoconjunctivitis Sicca Trial in United States (KPI-121 0.25% Ophthalmic Suspension, Vehicle of KPI-121

Completed
Has Results
  • Dry Eye Syndromes
  • Keratoconjunctivitis Sicca
  • KPI-121 0.25% Ophthalmic Suspension
  • Vehicle of KPI-121 0.25% Ophthalmic Suspension
  • Phoenix, Arizona
  • +59 more
Jan 19, 2021

Keratoconjunctivitis Sicca Trial in United States (R348 Ophthalmic Solution, 0.2%, R348 Ophthalmic Solution, 0.5%, Placebo)

Completed
Has Results
  • Keratoconjunctivitis Sicca
  • R348 Ophthalmic Solution, 0.2%
  • +2 more
  • Artesia, California
  • +19 more
Aug 9, 2016

Establish Referent Values for Dry Eye Disease

Completed
Has Results
  • Keratoconjunctivitis Sicca
    • San Diego, California
    • +9 more
    Apr 13, 2016

    Keratoconjunctivitis Sicca, Dry Eye Trial in United States (rebamipide 2% ophthalmic suspension, eye drops)

    Completed
    • Keratoconjunctivitis Sicca
    • Dry Eye
    • rebamipide 2% ophthalmic suspension
    • placebo eye drops
    • Mesa, Arizona
    • +18 more
    Jan 9, 2012

    Keratoconjunctivitis Sicca Trial in United States (Rebamipide)

    Completed
    • Keratoconjunctivitis Sicca
    • Birmingham, Alabama
    • +59 more
    Oct 31, 2006